Nevro Corp. (NYSE:NVRO) Receives $6.43 Consensus Target Price from Brokerages
Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...
Nevro (NYSE:NVRO) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com initiated coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research note issued on ...
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Wave Life Sciences (WVE) and Nevro Corp (NVRO)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alpha Teknova (TKNO – Research Report), Wave Life Sciences ...
Le Lézard6d
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter and full-year 2024 ...